Study of Afuresertib Monotherapy in Japanese Relapsed Multiple Myeloma Patients
Clinical trial NCT02177682 · TERMINATED
Trial details
- NCT number
- NCT02177682
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-13
- Primary completion
- 2017-02-09
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.